# Project-Cancer-2026-03
Advanced blueprint for Chronos-7 (Gen-2): A nitrooxy-pyrrolidine therapeutic designed to overcome tumor hypoxia. Features a dual-action mechanism targeting ferroptosis and oxygen-independent nitrosative stress. Includes 3-pot synthesis protocol.
